3916-78-7

Usage

Uses

Due to the limited information available, specific applications of 6-chloropyridazine-3-thiol cannot be accurately listed. However, based on its chemical structure and functional groups, it may have potential uses in various industries, such as:
Used in Pharmaceutical Industry:
6-Chloropyridazine-3-thiol could be used as an intermediate or building block in the synthesis of pharmaceutical compounds, given its unique molecular structure and functional groups.
Used in Chemical Synthesis Industry:
As a member of the pyridazine family, 6-chloropyridazine-3-thiol may be utilized in the synthesis of various organic compounds, including agrochemicals, dyes, and other specialty chemicals.
Used in Research and Development:
6-Chloropyridazine-3-thiol may be employed in research and development settings to explore its chemical properties, reactivity, and potential applications in different fields.

InChI:InChI=1/C4H3ClN2S/c5-3-1-2-4(8)7-6-3/h1-2H,(H,7,8)

Upstream product

• 141-30-0 3,6-dichlorpyridazine 

Downstream Products

• 7145-61-1 3-chloro-6-(methylsulfanyl)pyridazine 
• 17284-97-8 3-Chloro-6-hydrazinopyridazine 
• 88538-48-1 3-chloro-pyridazine-6-sulphonamide 

Relevant academic research and scientific papers

Synthesis of water-soluble pyridazine derivative and application thereof

The invention discloses synthesis and an application of a water-soluble pyridazine derivative, belongs to the technical field of synthesis and an application of a water-soluble pyridazine derivative corrosion inhibitor, and particularly relates to synthesis of a water-soluble heterocyclic corrosion inhibitor containing two nitrogen atoms and an application of the water-soluble heterocyclic corrosion inhibitor to corrosion inhibition of copper in a sulfuric acid solution with the concentration of 0.5 mol/L. The metallic copper and alloy thereof are widely applied to industries such as electrical industry, mechanical industry, traffic industry, ship industry and the like, but the copper is also subjected to serious corrosion in an acidic or marine environment. At present, the use of an organic corrosion inhibitor is one of the most effective ways for inhibiting the corrosion of copper. Although an existing heterocyclic organic corrosion inhibitor containing atoms such as nitrogen, oxygen, phosphorus and sulfur has a certain corrosion inhibition effect on copper in a sulfuric acid solution, most organic matters in the heterocyclic organic corrosion inhibitor are poor in water solubility and low in corrosion inhibition efficiency. In order to overcome the defects in the prior art, the water-soluble pyridazine derivative containing multiple heteroatoms is synthesized and serves as a corrosion inhibitor of metal copper in a sulfuric acid solution with the concentration of 0.5 mol/L.

Proton pump inhibitors

A proton pump inhibitor containing a compound represented by the formula (I) wherein X and Y are the same or different and each is a bond or a spacer having 1 to 20 carbon atoms in the main chain, R 1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, R 2 , R 3 and R 4 are the same or different and each is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted thienyl group, an optionally substituted benzo[b]thienyl group, an optionally substituted furyl group, an optionally substituted pyridyl group, an optionally substituted pyrazolyl group, an optionally substituted pyrimidinyl group, an acyl group, a halogen atom, a cyano group or a nitro group, R 5 and R 6 are the same or different and each is a hydrogen atom or an optionally substituted hydrocarbon group, which has a superior proton pump action and shows an antiulcer activity and the like after conversion to a proton pump inhibitor in the body, or a salt thereof. or a prodrug thereof is provided.

SULFONYL COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN

The present invention relates to sulfonyl compounds that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.

NOVEL PHENYLPYRROLE DERIVATIVE

The present invention relates to a compound or a pharmacologically acceptable salt thereof having superior glucokinase activating activity, and is a compound represented by general formula (I), or pharmacologically acceptable salt thereof: [wherein, A represents, for example, an oxygen atom or sulfur atom, R1 represents, for example, a C1-C6 alkyl group, a C1-C6 alkoxy group or a C1-C6 halogenated alkyl group, A and R1 together with the carbon atom bonded thereto form a heterocyclic group that may be substituted with 1 to 3 group(s) independently selected from Substituent Group α, R2 represents a phenyl group that may be substituted with 1 to 5 group(s) independently selected from Substituent Group α or a heterocyclic group that may be substituted with 1 to 3 group(s) independently selected from Substituent Group α, R3 represents a hydroxy group or a C1-C6 alkoxy group, and Substituent Group α consists of, for example, a halogen atom, a C1-C6 alkyl group, a C1-C6 alkyl group substituted with 1 or 2 hydroxy group(s), a C1-C6 alkylsulfonyl group, and a group represented by the formula -V-NR5R6 (wherein, V represents a carbonyl group or a sulfonyl group, and R5 and R6 may be the same or different and respectively represent a hydrogen atom or a C1-C6 alkyl group, or R5 and R6 together with the nitrogen atom bonded thereto form a 4- to 6-membered saturated heterocycle that may be substituted with 1 or 2 group(s) independently selected from a C1-C6 alkyl group and a hydroxy group, and the 4- to 6-membered saturated heterocycle may further contain one oxygen atom or nitrogen atom)].

Acid secretion inhibitor

The present invention provides a compound having a superior acid secretion inhibitory effect and showing an antiulcer activity and the like. The present invention provides a compound represented by the formula (I) wherein R1 is a nitrogen-containing monocyclic heterocyclic group optionally condensed with a benzene ring or a heterocycle, the nitrogen-containing monocyclic heterocyclic group optionally condensed with a benzene ring or a heterocycle optionally has substituent(s), R2 is an optionally substituted C6-14 aryl group, an optionally substituted thienyl group or an optionally substituted pyridyl group, R3 and R4 are each a hydrogen atom, or one of R3 and R4 is a hydrogen atom and the other is an optionally substituted lower alkyl group, an acyl group, a halogen atom, a cyano group or a nitro group, and R5 is an alkyl group or a salt thereof.

PROTON PUMP INHIBITORS

A proton pump inhibitor containing a compound represented by the formula (I) wherein X and Y are the same or different and each is a bond or a spacer having 1 to 20 carbon atoms in the main chain, R1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, R2, R3 and R4 are the same or different and each is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted thienyl group, an optionally substituted benzo[b]thienyl group, an optionally substituted furyl group, an optionally substituted pyridyl group, an optionally substituted pyrazolyl group, an optionally substituted pyrimidinyl group, an acyl group, a halogen atom, a cyano group or a nitro group, R5 and R6 are the same or different and each is a hydrogen atom or an optionally substituted hydrocarbon group, which has a superior proton pump action and shows an antiulcer activity and the like after conversion to a proton pump inhibitor in the body, or a salt thereof. or a prodrug thereof is provided.

PROTON PUMP INHIBITORS

Proton pump inhibitors which have excellent proton pumping activity and which can be converted in vivo into proton pump inhibitors to exhibit antiulcer effect and so on, containing compounds represented by the general formula (I) or salts thereof or prodrugs of the same: (I) wherein X and Y are each independently a free valency or a spacer whose main chain has 1 to 20 carbon atoms; R1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; R2, R3 and R4 are each independently hydrogen, an optionally substituted hydrocarbon group, optionally substituted thienyl, optionally substituted benzo[b]thienyl, optionally substituted furyl, optionally substituted pyridyl, optionally substituted pyrazolyl, optionally substituted pyrimidinyl, acyl, halogeno, cyano, or nitro; and R5 and R6 are each independently hydrogen or an optionally substituted hydrocarbon group.

Metalation of t-Butyl Sulfoxides, Sulfones and Sulfonamides of Pyridazine and Pyrazine. Metalation of Diazines. XX

In the pyridazine series, the use of tert-butylsulfinyl and tert-butylsulfonyl as ortho directing groups for metalation has been tested. Various functionalized products were obtained in good yields. In the case of 3-tert-burylsulfinyl-6-methoxypyridazine, the metalation was regioselective in ortho to the sulfinyl group. The metalation of 2-tert-butylsulfinyl and 2-tert-butylsulfonylpyrazine gave low to moderate yields. Synthesis of diazinesulfonamides were improved and the metalation of N-tert-butylsulfonamidopyrazine was achieved.

3-Pyridazine derivatives and their use in rubber

Thiols, disulfides and sulfenamides of certain pyridazines are effective accelerators in the sulfur vulcanization of rubber. These compounds, based on 3-pyridazine show improved rates of vulcanization and states of cure compared with known sulfenamide acc